𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Subcellular distribution of the insulin-like growth factor (IGF) binding proteins (IGFBPs) 2 and 3 in articular chondrocytes

✍ Scribed by Tiezheng Sun; Ernst B. Hunziker; Teresa I. Morales

Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
147 KB
Volume
26
Category
Article
ISSN
0736-0266

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The insulin‐like growth factor (IGF) is a major anabolic regulator in articular cartilage. The IGF‐binding proteins (IGFBPs) are increased during osteoarthritis (OA), but the function of the later proteins remains unknown. In general, the IGFBPs are pluripotential effectors capable of IGF regulation and of acting on their own to control key cell functions, including survival and proliferation. The independent functions are often associated with their cell location, and therefore this study explores the distribution of IGFBP‐2 and IGFBP‐3 in articular chondrocytes. Immunohistochemistry was used to localize IGFBP‐2 in normal human articular cartilage. Bovine chondrocytes were used for subcellular fractionation (hypotonic cell lysis) under nonreducing conditions and nuclear purification (centrifugation on sucrose cushions). Cell fraction markers and IGFBPs were assayed in the subcellular fractions by Western immunoblot. The IHC results showed association of IGFBP‐2 with chondrocytes, but not with the nuclei. Subcellular fractionation of isolated chondrocytes yielded intact nuclei as assessed at the light microscopic level; the nuclear marker histone H1 was exclusively associated with this fraction. More than 90% of the cytoplasmic marker GAPDH and all the detectable IGFBP‐2 were in the cytoplasmic fraction. Immunoreactive IGFBP‐3 was found in the cytoplasmic and peri‐nuclear/nuclear fractions. Chondrocytes contain intracellular IGFBP‐2 and IGFBP‐3 but only IGFBP‐3 is associated with nuclei. This suggests the hypothesis that the actions of these IGFBPs in articular cartilage extend beyond the classic modulation of IGF receptor action. © 2008 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 26:1421–1427, 2008

📜 SIMILAR VOLUMES

Insulin-like growth factors (IGF-I, free
Insulin-like growth factors (IGF-I, free IGF-I, and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation
✍ Herbert Yu; Jehangir Mistry; Michael J. Nicar; M. Javad Khosravi; Anastasia Diam 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 2 views

Insulin-like growth factors (IGFs) and IGF binding proteins (IGFBPs) play an important role in cell growth and differentiation. Clinical and epidemiological studies have indicated that measuring IGFs and IGFBPs in blood has potential implications in assessing growth-related abnormalities and risks o

Polymerization of insulin-like growth fa
Polymerization of insulin-like growth factor-binding protein-1 (IGFBP-1) potentiates IGF-I actions in placenta
✍ Hiromi Shibuya; Keiji Sakai; Maryam Kabir-Salmani; Yuichi Wachi; Mitsutoshi Iwas 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB

## Abstract Insulin‐like growth factor (IGF)‐binding protein‐1 (IGFBP‐1), the main secretory protein of decidua that binds to IGFs and has been shown to inhibit or stimulate IGFs' bioactivities. Polymerization, one of the posttranslational modifications of IGFBP‐1, has been shown to lead to loss of

Advanced glycosylation end products (AGE
Advanced glycosylation end products (AGEs), insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 (IGFBP-3) in patients with Type 2 diabetes mellitus
✍ Ma. Eugenia Garay-Sevilla; Laura Eugenia Nava; Juan Manuel Malacara; Kazimierz W 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 126 KB 👁 1 views

Background Advanced glycosylation end product (AGE) formation is a major mechanism for the development of complications in diabetes, and the possible roles of insulin-like growth factor 1 (IGF-1) and IGF binding protein 3 (IGFBP-3) are not clearly established. ## Methods We examined the associati

Modulation of insulin-like growth factor
Modulation of insulin-like growth factor actions in L6A1 myoblasts by insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5: A dual role for IGFBP-5
✍ Daina Z. Ewton; Sharon A. Coolican; Subburaman Mohan; Steven D. Chernausek; Jame 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 213 KB 👁 2 views

We have previously shown that the insulin-like growth factors (IGFs) stimulate both proliferation and differentiation of skeletal muscle cells in culture, and that these actions in L6A1 muscle cells may be modulated by three secreted IGF binding proteins (IGFBPs), IGFBP-4, -5, and -6. Since we found